MedTrace Logo

Prediction of Preterm Delivery by Serum Ischemia Modified Albumin, Biglycan and Decorin Levels in Women With Threatened Preterm Labour

NCT04451928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2021-03-03

No results posted yet for this study

Summary

In this study, the levels of ischemia modified albumin, biglycan and decorin in the serums of pregnant women hospitalized for preterm labor will be examined. Their serum levels will be compared between women having preterm and term delivery. Their accuracy will be asessed in predicting preterm birth.

Conditions

Interventions

DIAGNOSTIC_TEST

Serum sample analysis

Analysis of the levels of ischemia-modified albumin, biglycan and decorin levels

Sponsors & Collaborators

  • Ismail Biyik

    lead OTHER

Principal Investigators

  • Ismail Biyik, MD · Kütahya Medical Sciences University

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-02-05
Completion
2021-02-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04451928 on ClinicalTrials.gov